Literature DB >> 33317403

Computer-aided modeling of triazole analogues, docking studies of the compounds on DNA gyrase enzyme and design of new hypothetical compounds with efficient activities.

Shola Elijah Adeniji1, David Ebuka Arthur2, Mustapha Abdullahi1, Ayuba Abdullahi3, Fabian Audu Ugbe1.   

Abstract

The increasing problem of multi-drug resistant-tuberculosis has focused attention on developing new drugs that are not only active against drug-resistant tuberculosis, but also shorten the lengthy therapy. Therefore, this work employs the application of modeling technique to predict the inhibition activities of some prominent compounds which been reported to be efficient against Mycobacterium tuberculosis. To accomplish the purpose of this work, multiple regression and genetic function approximation were adopted to create the model. The established model was swayed with topological descriptors; MATS7s, SpMin4_Bhv, TDB3v and RDF70v. More also, interactions between the compounds and the target protein 'DNA gyrase' were evaluated via molecular docking approach utilizing the PyRx and discovery studio simulation software. Based on the docking analysis, compound 20 has the most noticeable binding affinity of -16.5 kcal/mol. Therefore, compound 20 served as a reference structural template and insight to design fourteen novel hypothetical agents with more prominent anti-tubercular activities. More also, compound 20j was observed with the highest activity among the designed compounds with a prominent binding affinity of -24.3 kcal/mol. Therefore, this research recommends in-vivo, in-vitro screening and pharmacokinetic properties to be carried out in order to determine the toxicity of the designed compounds.Communicated by Ramaswamy H. Sarma.

Entities:  

Keywords:  DNA gyrase; Descriptors; QSAR; triazole; tuberculosis

Mesh:

Substances:

Year:  2020        PMID: 33317403     DOI: 10.1080/07391102.2020.1852963

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  2 in total

1.  Theoretical modeling and design of some pyrazolopyrimidine derivatives as Wolbachia inhibitors, targeting lymphatic filariasis and onchocerciasis.

Authors:  Fabian Audu Ugbe; Gideon Adamu Shallangwa; Adamu Uzairu; Ibrahim Abdulkadir
Journal:  In Silico Pharmacol       Date:  2022-05-07

2.  Binding profile of protein-ligand inhibitor complex and structure based design of new potent compounds via computer-aided virtual screening.

Authors:  Gideon Adamu Shallangwa; Shola Elijah Adeniji
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2021-06-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.